# Oxidative Stress and Hemodialysis Access Failure

> **NCT00410449** · — · COMPLETED · sponsor: **National Institute of Environmental Health Sciences (NIEHS)** · enrollment: 35 (—)

## Conditions studied

- End Stage Renal Disease
- Hemodialysis

## Interventions

- **DRUG:** Alpha tocopherol

## Key facts

- **NCT ID:** NCT00410449
- **Lead sponsor:** National Institute of Environmental Health Sciences (NIEHS)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** —
- **Final completion:** 2004-05
- **Target enrollment:** 35 (—)
- **Last updated:** 2015-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410449, "Oxidative Stress and Hemodialysis Access Failure". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00410449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
